Vascular endothelial growth factor-A 47 and chemokine ligand-2 (CCL2) in Amyotrophic Lateral Sclerosis (ALS) patients

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Gupta, Pawan K ^a   Prabhakar, Sudesh ^a   Sharma, Suresh ^b   Anand, Akshay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN A; CCL2 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INDIA; MALE; MEAT; MICROGLIA; MULTIVARIATE ANALYSIS; NEURAL STEM CELL; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN SYNTHESIS; SURVIVAL TIME; UNIVARIATE ANALYSIS; UPREGULATION; AGED; BLOOD; CEREBROSPINAL FLUID; MIDDLE AGED; SURVIVAL RATE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CHEMOKINE CCL2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955835302     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-47     Document Type: Article

References (24)

1. Zheng C, Nennesmo I, Fadeel B, Henter JI. Vascular endothelial growth factor prolongs survival in a transgenic model of ALS. Ann Neurol 2004, 56:564-567. 10.1002/ana.20223, 15389897.
2. Li B, Xu W, Luo C, Gozal D, Liu R. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res Mol Brain Res 2003, 111:155-164.
3. Meng H, Zhang Z, Zhang R, Liu X, Wang L, Robin AM, Chopp M. Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitors. Neurosci Lett 2006, 393:97-101. 10.1016/j.neulet.2005.09.044, 16269210.
4. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 2004, 55:221-235. 10.1002/ana.10805, 14755726.
5. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 2002, 22:308-317.
6. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001, 193:713-726. 10.1084/jem.193.6.713, 2193420, 11257138.
7. Hong KH, Ryu J, Han KH. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 2005, 105:1405-1407. 10.1182/blood-2004-08-3178, 15498848.
8. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessmentsof respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999, 169:13-21. 10.1016/S0022-510X(99)00210-5, 10540002.
9. Prabhakar S, Vinish M, Das CP, Anand A. Occurrence of PARK2 Mutations in a Never-Smoker Population with Parkinson's Disease in North India. Neuroepidemiology 2010, 35:152-159. 10.1159/000313855, 20571283.
10. Bradley WG. Commentary on Professor Stephen Hawking's disability advice. Annals of Neurosciences 2009, 16:101-102.
11. Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci 2008, 272:60-70. 10.1016/j.jns.2008.04.034, 18550082.
12. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002, 59:280-282.
13. Osuntokun BO, Adeuja AOG, Bademosi O. The prognosis of motor neuron disease in Nigerian Africans. A prospective study of 92 patients. Brain 1974, 97:385-394. 10.1093/brain/97.1.385, 4434185.
14. Nygren I, Larsson A, Johansson A, Askmark H. VEGF-A is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis. Neuroreport 2002, 13:2199-201. 10.1097/00001756-200212030-00007, 12488796.
15. Devos D, Moreau C, Lassalle P, Perez T, De Seze J, Brunaud-Danel V, Destée A, Tonnel AB, Just N. Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology 2004, 62:2127-2129.
16. Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JH, Hardiman O. Elevated serum angiogenin levels in ALS. Neurology 2006, 67:1833-1836. 10.1212/01.wnl.0000244466.46020.47, 17130418.
17. McCloskey DP, Hintz TM, Scharfman HE. Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects. Brain Res Bull 2008, 76:36-44. 10.1016/j.brainresbull.2007.11.018, 2422999, 18395608.
18. Bogaert E, Van Damme P, Poesen K, Dhondt J, Hersmus N, Kiraly D, Scheveneels W, Robberecht W, Van Den Bosch L. VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiol Aging 2008,
19. Madrigal JL, Leza JC, Polak P, Kalinin S, Feinstein DL. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 2009, 29:263-267. 10.1523/JNEUROSCI.4926-08.2009, 19129402.
20. Liu XS, Zhang ZG, Zhang RL, Gregg SR, Wang L, Yier T, Chopp M. Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke. J Neurosci Res 2007, 85:2120-2125. 10.1002/jnr.21359, 17510981.
21. Magge SN, Malik SZ, Royo NC, Chen HI, Yu L, Snyder EY, O'Rourke DM, Watson DJ. Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors. J Neurosci Res 2009, 87:1547-1555. 10.1002/jnr.21983, 19125409.
22. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999, 48:1131-1137. 10.2337/diabetes.48.5.1131, 10331420.
23. Schichor C, Birnbaum T, Etminan N, Schnell O, Grau S, Miebach S, Aboody K, Padovan C, Straube A, Tonn JC, Goldbrunner R. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp Neurol 2006, 199:301-310. 10.1016/j.expneurol.2005.11.027, 16574102.
24. El-Badri NS, Hakki A, Saporta S, Liang X, Madhusodanan S, Willing AE, Sanberg CD, Sanberg PR. Cord blood mesenchymal stem cells: Potential use in neurological disorders. Stem Cells Dev 2006, 15:497-506. 10.1089/scd.2006.15.497, 16978054.